# TCL Healthcare and Eckert & Ziegler BEBIG form joint venture for brachytherapy in China

TCL Healthcare Equipment (Shanghai) and Eckert & Ziegler BEBIG signed a joint venture agreement to develop, manufacture, and distribute HDR afterloaders for brachytherapy in China. The JV, TCL Eckert & Ziegler BEBIG Healthcare (Wuxi), is 51% owned by TCL and 49% by Eckert & Ziegler.

- Type: Partnership
- Announced: 2019-07-31
- Where: Wuxi, China, China
- Status: announced
- Products: High Dose Rate Brachytherapy afterloader
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [TCL Eckert & Ziegler BEBIG Healthcare (Wuxi)](https://endata.com/companies/41012.md)
- [Eckert & Ziegler BEBIG SA](https://endata.com/companies/35484.md) (partner)
- [TCL Healthcare Equipment (Shanghai)](https://endata.com/companies/41011.md) (partner)

## Sources

- [haocapital.net](http://haocapital.net/2019/08/tcl-healthcare-enters-the-high-dose-rate-brachytherapy-solutions-market-in-china/), 2019-07-31: "The parties will develop, manufacture and distribute an HDR afterloader for the Chinese market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.